Literature DB >> 24699919

Seeking a standard for adequate pathologic lymph node staging in primary bladder carcinoma.

Lu Wang1, Kumaran Mudaliar, Vikas Mehta, Güliz A Barkan, Marcus L Quek, Robert C Flanigan, Maria M Picken.   

Abstract

The purposes of this study are to evaluate the adequacy of pathologic lymph node (LN) staging in radical cystectomy specimens from patients with urothelial carcinoma of the bladder and to analyze the frequency of LN metastases among different anatomic regions. All radical cystectomies performed for primary urothelial bladder cancer over a 5-year period (January 2007-September 2012) at a single institution were reviewed. Particular attention was paid to the total number of LNs examined, the number and location of LNs with metastases (positive LNs), and the presence or absence of extranodal tumor extension and/or lymphovascular invasion in the cystectomy specimen. Results and data were analyzed with Origin 6.0 and Microsoft Office Excel 2007 software. A total of 248 radical cystectomies with 8,432 LNs were reviewed. A total of 60 (24 %) cases, with 274 positive LNs out of the 1,982 total (13.8 %), were identified with a male to female ratio of 6.5:1 (52 male, 8 female patients). The average number of LNs examined in each case was 33.0 ± 20.9 (range 5-112). The average number of positive LNs identified in each case was 4.5 ± 4.8 (range 1-26). Among all of the LNs, the hypogastric/obturator (internal iliac) LNs were the most commonly submitted (35.2 %) and also yielded the highest number of positive LNs (46.0 %). On average, for cases staged pN1 and pN2, there was one positive LN per 17.8 and 8.9 LNs examined from the primary drainage LNs, respectively. For pN3 cases, one out of 4.4 secondary drainage LNs was found to be positive. Similarly, one out of 4.0 distant LNs was found to be positive in cases with pM1 staging. Our study suggests that, on average, 23 LNs (including 18 primary drainage LNs and five secondary drainage LNs) should be submitted for optimal pN staging. For adequate pM1 staging, an average of four distal LNs should be evaluated. In total, an average of 27 LNs (23 for pN staging and 4 for pM staging) should be examined in radical cystectomy specimens. We also propose to stratify the number of positive LNs according to the drainage area.

Entities:  

Mesh:

Year:  2014        PMID: 24699919     DOI: 10.1007/s00428-014-1575-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  32 in total

1.  Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.

Authors:  B H Bochner; H W Herr; V E Reuter
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

2.  Superiority of ratio based lymph node staging for bladder cancer.

Authors:  Harry W Herr
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

3.  Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.

Authors:  Ryan P Dorin; Siamak Daneshmand; Manuel S Eisenberg; Shahin Chandrasoma; Jie Cai; Gus Miranda; Peter W Nichols; Donald G Skinner; Eila C Skinner
Journal:  Eur Urol       Date:  2011-07-14       Impact factor: 20.096

4.  Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.

Authors:  Matthias May; Edwin Herrmann; Christian Bolenz; Arne Tiemann; Sabine Brookman-May; Hans-Martin Fritsche; Maximilian Burger; Alexander Buchner; Christian Gratzke; Christian Wülfing; Lutz Trojan; Jörg Ellinger; Derya Tilki; Christian Gilfrich; Thomas Höfner; Jan Roigas; Mario Zacharias; Sven Gunia; Wolf F Wieland; Markus Hohenfellner; Maurice S Michel; Axel Haferkamp; Stefan C Müller; Christian G Stief; Patrick J Bastian
Journal:  Eur Urol       Date:  2011-01-28       Impact factor: 20.096

5.  How close are we to establishing standards of lymphadenectomy for invasive bladder cancer?

Authors:  Pankaj P Dangle; Robert R Bahnson; Kamal S Pohar
Journal:  Ther Adv Urol       Date:  2009-08

6.  The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.

Authors:  Jonathan L Wright; Daniel W Lin; Michael P Porter
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

7.  Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.

Authors:  Badrinath R Konety; Sue A Joslyn; Michael A O'Donnell
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

8.  External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.

Authors:  Alexandra Masson-Lecomte; Dimitri Vordos; Andras Hoznek; René Yiou; Yves Allory; Claude C Abbou; Alexandre de la Taille; Laurent Salomon
Journal:  Ann Surg Oncol       Date:  2012-12-04       Impact factor: 5.344

Review 9.  The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.

Authors:  Alexander Karl; Peter R Carroll; Jürgen E Gschwend; Ruth Knüchel; Francesco Montorsi; Christian G Stief; Urs E Studer
Journal:  Eur Urol       Date:  2009-01-13       Impact factor: 20.096

10.  Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.

Authors:  John P Stein; Jie Cai; Susan Groshen; Donald G Skinner
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

View more
  2 in total

1.  SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis.

Authors:  Jianhua Huang; Cheng Li; Wentao Zhang; Fuhan Yang; Ruiliang Wang; Junfeng Zhang; Wei Li; Xudong Yao
Journal:  Ann Transl Med       Date:  2021-09

2.  Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.

Authors:  Shaoxu Wu; Junjiong Zheng; Yong Li; Zhuo Wu; Siya Shi; Ming Huang; Hao Yu; Wen Dong; Jian Huang; Tianxin Lin
Journal:  EBioMedicine       Date:  2018-08-02       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.